BR100 Decreased By (-0.15%)
BR30 Decreased By (-0.74%)
KSE100 Decreased By (-0.41%)
KSE30 Decreased By (-0.67%)
BECO 5.80 Decreased By ▼ -0.23 (-3.81%)
BML 58.03 Increased By ▲ 5.28 (10.01%)
BOP 33.85 Decreased By ▼ -0.40 (-1.17%)
CNERGY 8.15 Decreased By ▼ -0.01 (-0.12%)
DCL 11.77 Decreased By ▼ -0.57 (-4.62%)
FCCL 53.35 Decreased By ▼ -0.54 (-1%)
FCSC 5.40 Increased By ▲ 0.18 (3.45%)
FFL 17.89 Decreased By ▼ -0.14 (-0.78%)
FNEL 1.31 Increased By ▲ 0.01 (0.77%)
HUMNL 11.06 Increased By ▲ 0.06 (0.55%)
KEL 8.05 Decreased By ▼ -0.06 (-0.74%)
KOSM 5.45 Increased By ▲ 0.07 (1.3%)
MLCF 87.19 Decreased By ▼ -0.86 (-0.98%)
NBP 184.60 Decreased By ▼ -1.88 (-1.01%)
PACE 11.62 Increased By ▲ 0.90 (8.4%)
PAEL 40.31 Increased By ▲ 0.37 (0.93%)
PIAHCLA 26.10 Decreased By ▼ -0.07 (-0.27%)
PIBTL 17.09 Decreased By ▼ -0.23 (-1.33%)
PPL 228.40 Decreased By ▼ -4.38 (-1.88%)
PRL 34.59 Decreased By ▼ -0.36 (-1.03%)
PTC 67.35 Decreased By ▼ -0.21 (-0.31%)
SEARL 91.00 Increased By ▲ 0.07 (0.08%)
SSGC 26.90 Decreased By ▼ -0.27 (-0.99%)
TELE 8.53 Decreased By ▼ -0.04 (-0.47%)
THCCL 66.14 Increased By ▲ 6.01 (10%)
TPLP 9.29 Increased By ▲ 0.53 (6.05%)
TREET 24.59 Increased By ▲ 0.05 (0.2%)
TRG 71.69 Decreased By ▼ -0.06 (-0.08%)
WAVES 10.98 Increased By ▲ 1.00 (10.02%)
WTL 1.28 Increased By ▲ 0.02 (1.59%)
Markets

European shares extend gains after German PMI relief

The pan-European STOXX 600 climbed 1.2pc following four consecutive sessions of declines. The report added to
Published January 24, 2020 Updated January 24, 2020 10:42am
By
  • The pan-European STOXX 600 climbed 1.2pc following four consecutive sessions of declines.
  • The report added to investor relief after the World Health Organization stopped short of calling a virus outbreak in China a global emergency.
  • Investors are now waiting for UK PMI readings, due at 0930 GMT.

European shares extended gains on Friday after a key monthly business activity report from Germany suggested the euro zone's largest economy may be picking up some steam at the start of 2020.

The report added to investor relief after the World Health Organization stopped short of calling a virus outbreak in China a global emergency.

The pan-European STOXX 600 climbed 1.2pc following four consecutive sessions of declines.

Germany's DAX was on course for its best day in about two weeks after IHS Markit's Purchasing Managers' Index (PMI) showed the country's private sector gained momentum in January and a pullback in manufacturing had eased.

The report comes on the heels of a ZEW survey, which showed the recent truce in the U.S.-China trade dispute left German investors at their most optimistic since mid-2015.

The PMI data "seems to confirm (European Central Bank President) Lagarde's remarks that the economic risks have become less pronounced so that's a positive," said Teeuwe Mevissen, senior eurozone market economist at Rabobank.

"At the same time she said interest rates will remain low for the foreseeable future so even as the risks have become less pronounced, markets can still count on the ECB to maintain interest rates at very low levels."

Lagarde struck a slightly more dovish tone than some had expected following the central bank's first policy meeting of he year on Thursday.

Gains in bank stocks provided the biggest support to the benchmark index. All major European subsectors were trading higher.

Investors are now waiting for UK PMI readings, due at 0930 GMT, which will be crucial ahead of the Bank of England's interest rate decision next week.

Among stocks, Bayer provided the biggest boost to DAX after a report on a possible out-of-court settlement of a U.S. jury trial over allegations that its weed killer Roundup causes cancer.

Swedish telecoms equipment group Ericsson was on track for its worst day in about six months after it reported a smaller-than-expected rise in fourth-quarter core earnings. Shares of its rival Nokia slipped 0.8pc.

Nokian Tyres hit a more than three month low as the Finnish tyre maker forecast its 2020, sales and operating result to significantly decline from a year earlier due to weak performance in its Russia operations.

Shares of French pharma company Ipsen tumbled 22pc to the bottom of STOXX 600 after it paused dosing in rare bone diseases drug, palovarotene.

Comments

Comments are closed for this article.